The increasing application of blow fill seal technology results into a lesser requirement of labor. Additionally, the technology can help manufacturing companies to reduce a range of facility-related costs. This is made possible because the technology requires a smaller warehouse for storing materials and reduced utility consumption, which involves zero water for injection or washing requirement. The technology is capable of producing a very high equipment-effectiveness that results in a higher output for investment.
Blow fill seal (BFS) technology is highly sought-after as a preferred packaging solution in pharmaceutical manufacturing. It utilizes a single integrated machine to produce formulated drugs aseptically without any human intervention. According to Future Market Insights (FMI), the BFS technology market is set to reach US$ 2.6 Bn by the end of 2021. Overall growth forecast remains positive for the market, especially as demand for effective packaging technology continues to rise across various industries.
Get Sample of the report : https://www.futuremarketinsights.com/reports/sample/rep-gb-4407
Unither Pharmaceuticals SAS, Catalent, Inc., Curida AS, Unipharma LLC, Weiler Engineering Inc, GlaxoSmithKline plc, Takeda Pharmaceuticals International AG, Nephron Pharmaceuticals Corporation, Horizon Pharmaceutical Inc, Brevetti Angela S.R.L, Recipharm AB, Laboratorios SALVAT, S.A, The Ritedose Corporation, Unicep Packaging, LLC, Pharmapack Co. Ltd, Amanta Healthcare Ltd., Automatic Liquid Packaging Solutions LLC, Asept Pak, Inc and SIFI Spa are some of the keyplayers in the blow fill seal technology market.
By using BFS technology, the plastic is blown, filled with the formulated product and sealed inside the machine continuously without any kind of external contamination. It is a fast, precise, and safe method for pharmaceutical filling and it uses lesser energy. The material used is often recyclable and more durable than glass. The machine is capable of producing different shapes according to the end user’s requirements. As BFS technology increases processing speed and supports contamination free packaging, this technology becomes a first choice of many end users.
Ask For Country-Specific Data: https://www.futuremarketinsights.com/ask-country-specific/rep-gb-4407
The BFS technology finds application across diverse industries. However, pharmaceutical industry remains its key end user. Main products produced using this technology are the bottles, ampoules, vials and pre-filled syringes, etc. which are used in filling of medicines, vaccines, ophthalmic, respiratory, injectable drugs, wound care, and biologics. Apart from this, BFS technology has applications in food & beverage, cosmetic and personal care, and many other industries.
Blow Fill Seal Technology Aids in Curbing Medical Non Adherence Issues
Over the past two decades, medical adherence has created a very critical situation for healthcare & pharmaceutical industry.
For instance: in USA, according to FMI study, it has been noticed that ~40%-50% of prescribed medications are not taken by the patients appropriately. Along with this, according to a study conducted by the Intercontinental Medical Statistics (IMS) health, it has been noticed that the matter of not taking medicine appropriately at right time is costing patients more than $200 Bn.
Why is Blow Fill Seal Technology Gaining Traction?
There has been a rising demand for tailor-made and automated solutions, particularly from the developed countries. North America and Western Europe pharmaceutical industries are highly advanced and have been exhibiting a rising demand for biotechnology-derived drugs as well as new bio manufacturing formats
How is Demand for Unit Dose Packaging Affecting Blow Fill Seal Technology Market Growth?
Pharmaceutical packaging industry is witnessing a shift from conventional packaging types to more advanced pharmaceutical packaging forms. Innovation in packaging that can improve how patients manage their healthcare is also spurring the need for new packaging equipment
Blow fill seal technology is being adopted across the globe and it has been witnessing increasing demand from pharma sector in developing countries of Latin America and Asia Pacific for improvised medication. Unit-dose packaging, like syringes which are prefilled, are generating demand, which in turn is creating opportunities for blow fill seal technology in these regions.
Request Special Price : https://www.futuremarketinsights.com/request-special-price/rep-gb-4407
Key Questions Answered in the Report
Which is the most lucrative market for blow fill seal technology?
The U.S. currently leads the global market for blow fill seal technology. Sales in the U.S. will be account for a considerable share of the global market over the coming decade.
Which is the top-selling product associated with blow fill seal technology?
Prefilled syringes and injectable are highly sought-after in the blow full seal technology market. The demand for ampules is expected to grow at an impressive rate in the near future.
Which sector is accountable for driving sales of blow fill seal technology?
Blow fill seal technology is increasingly used by the pharmaceutical sector. It will continue accounting for majority sales in the market between 2021 and 2031.
About Us
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedIn| Twitter| Blogs